Advertisement

Advances in Therapy

, Volume 19, Issue 3, pp 109–118 | Cite as

Potential anti-inflammatory effects of topical retinoids and retinoid analogues

  • John E. Wolf
Article

Abstract

The topical retinoid tretinoin and topical retinoid analogues such as adapalene and tazarotene help normalize hyperkeratinization in acne vulgaris and have demonstrated significant anti-inflammatory effects in experimental trials. Inhibition of various immune factors, including the activity of leukocytes, the release of proinflammatory cytokines and other mediators, and the expression of transcription factors and toll receptors involved in immunomodulation, has emerged in both in vitro studies and in vivo animal experiments. These multiple mechanisms of action should encourage clinicians to consider these agents in the first-line management of inflammatory acne lesions.

Keywords

topical retinoids retinoid analogues acne vulgaris inflammation immunomodulation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Johnson BA, Nunley JR. Topical therapy for acne vulgaris. How do you choose the best drug for each patient?Postgrad Med. 2000;107:69–80.PubMedGoogle Scholar
  2. 2.
    Shalita A. The integral role of topical and oral retinoids in the early treatment of acne.J Eur Acad Dermatol Venereol. 2001;15(suppl 3):43–49.PubMedCrossRefGoogle Scholar
  3. 3.
    Webster GF. Inflammation in acne vulgaris.J Am Acad Dermatol. 1995;33:247–253.PubMedCrossRefGoogle Scholar
  4. 4.
    Norris JF, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions.Br J Dermatol. 1988;118:651–659.PubMedCrossRefGoogle Scholar
  5. 5.
    Ingham E, Walters CE, Eady EA, Cove JH, Kearney JN, Cunliffe WJ. Inflammation in acne vulgaris: failure of skin micro-organisms to modulate keratinocyte interleukin 1α production in vitro.Dermatology. 1998;196:86–88.PubMedCrossRefGoogle Scholar
  6. 6.
    Stingl G, Maurer D, Hauser C, Wolff K. The epidermis: an immunologic microenvironment. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds.Fitzpatrick’s Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill; 1999:343–370.Google Scholar
  7. 7.
    Lee WL, Shalita AR, Suntharalingam K, Fikrig SM. Neutrophil chemotaxis byPropionibacterium acnes lipase and its inhibition.Infect Immun. 1982;35:71–78.PubMedGoogle Scholar
  8. 8.
    Scott DG, Cunliffe WJ, Gowland G. Activation of complement—a mechanism for the inflammation in acne.Br J Dermatol. 1979;101:315–320.PubMedCrossRefGoogle Scholar
  9. 9.
    Brostoff J, Scadding GK, Male DK, Roitt IM.Clinical Immunology. New York, NY: Gower Medical; 1992.Google Scholar
  10. 10.
    Strauss JS, Thiboutot DM. Diseases of the sebaceous glands. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds.Fitzpatrick’s Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill; 1999:769–784.Google Scholar
  11. 11.
    Czernielewski J, Michel S, Bouclier M, Baker M, Hensby C. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne.J Eur Acad Dermatol Venereol. 2001; 15(suppl 3):5–12.PubMedCrossRefGoogle Scholar
  12. 12.
    Wauben-Penris PJJ, Cerneus DP, van den Hoven WE, Leuven PJMJ, den Brok JHAM, Hall DWR. Immunomodulatory effects of tretinoin in combination with clindamycin.J Eur Acad Dermatol Venereol. 1998;11(suppl 1):S2-S7.PubMedCrossRefGoogle Scholar
  13. 13.
    Oh G-S, Pae H-O, Seo W-G, et al. Inhibitory effect of retinoic acid on expression of inducible nitric oxide synthase gene in L929 cells.Immunopharmacol Immunotoxicol. 2001;23:335–342.PubMedCrossRefGoogle Scholar
  14. 14.
    Duvic M. Pharmacologic profile of tazarotene.Cutis. 1998;61(2 suppl):22–26.PubMedGoogle Scholar
  15. 15.
    Hensby C, Cavey D, Bouclier M, et al. The in vivo and in vitro anti-inflammatory activity of CD271: a new retinoid-like modulator of cell differentiation.Agents Actions. 1990;29:56–58.PubMedCrossRefGoogle Scholar
  16. 16.
    Shroot B, Michel S. Pharmacology and chemistry of adapalene.J Am Acad Dermatol. 1997; 36(suppl 1):S96-S103.PubMedCrossRefGoogle Scholar
  17. 17.
    Data on file. Galderma, LP, Fort Worth, Texas.Google Scholar
  18. 18.
    Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response.Nature. 2000;406:782–787.PubMedCrossRefGoogle Scholar
  19. 19.
    Bouclier M, Luginbuhl B, Shroot B, Hensby CN. Arachidonic acid induced ear oedema in four strains of rats and mice: a comparative study of anti-inflammatory drugs.Agents Actions. 1990; 29:62–64.PubMedCrossRefGoogle Scholar
  20. 20.
    Wolf JE. An update of recent clinical trials examining adapalene and acne.J Eur Acad Dermatol Venereol. 2001;15(suppl 3):23–29.PubMedCrossRefGoogle Scholar

Copyright information

© Health Communications Inc 2002

Authors and Affiliations

  • John E. Wolf
    • 1
  1. 1.Department of DermatologyBaylor College of MedicineHouston

Personalised recommendations